Preimplantation Embryo Gene Editing: Is This A Step Forward?
There have been recent news reports that a US startup has raised tens of millions of dollars to fund research into preimplantation embryo gene editing to prevent serious hereditary genetic diseases. This startup from San Francisco, called Preventive, has the backing of giants in technology like Sam Altman (CEO of OpenAI) and Brian Armstrong (CEO of cryptocurrency platform Coinbase). However, pushing the boundaries of human reproduction through preimplantation embryo gene editing has serious ramifications. It is not as simple as saying this technology, responsibly and safely applied, could cure hereditary genetic diseases and enable people to live longer and healthier lives.
Read More


